Inactivation (disinfection) processes
Protozoan cysts such as Entamoeba histolytica and Giardia lamblia are highly resistant to chlorine disinfection and may require prolonged contact times at high chlorine residuals (2–3 mg/l) to achieve 99.9% (3-log) inactivation. Clark, Read & Hoff (1989) have described a mathematical model for Giardia
Download Inactivation (disinfection) processes
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
7 Entamoeba histolytica - Universidad de las Américas Puebla
catarina.udlap.mx7 Entamoeba histolytica Entamoeba histolytica, protozoario comensal del intestino grueso, que en ocasiones invade la mucosa intestinal, y puede diseminarse por vía hemática, es el agente responsable de la amebiasis, afección cosmopolita.
หลักการเกิดโรคติดเชื้อ
www.med.nu.ac.th- Entamoeba histolytica , Giardia lambia , Isospora belli และ Cryptosporidium spp. ซึ่ง เป็น Intestinal protozoa ท าให้เกิดโรคที่ทางเดินอาหาร
Acute Diarrhea in Adults - AAFP Home
www.aafp.orgFeb 01, 2014 · Entamoeba histolytica, Yersinia. Other Generally milder disease Severe fluid loss can still occur, especially in malnourished patients Generally more severe disease. Information from references 7 ...
1. MALATTIE INFETTIVE E PARASSITARIE (001-139)
www.salute.gov.itIncl.: Infezioni dovute a Entamoeba histolytica Escl.: amebiasi dovute ad organismi diversi da Enta-moeba histolytica (007.8) 006.0 Dissenteria amebica acuta senza menzione di ascesso Amebiasi acuta 006.1 Amebiasi intestinale cronica senza menzio-ne di ascesso Cronica: amebiasi dissenteria amebica 006.2 Colite amebica non dissenterica